Philadelphia Opioid Dealer Gets 5 Years in Prison
Federal prosecutors secured prison sentence in long-running Philadelphia oxycodone distribution conspiracy.
Sara is a credited writer, editor, contributor, and essayist, as well as a novelist and poet with more than two decades of experience in media arts. A seasoned publishing professional, she's worked for newspapers, magazines and book publishers in content digitization, editorial, acquisitions and intellectual property. Sara is a member of the International Association of Writers & Editors, has received numerous awards and has been an invited speaker at a Careers in Publishing & Authorship event at Michigan State University and a Reading and Writing Instructor at Sylvan Learning Center. She is also a mental health therapist, clinical supervisor and entrepreneur, holding an MBA degree with a concentration in Marketing and an MA in Clinical Mental Health Counseling (graduating with a 4.2/4.0 GPA). Additionally, she is a member of Chi Sigma Iota, was on her local chapter's board, and a 2020 recipient of the Donald D. Davis scholarship recognizing social responsibility. Sara is certified in children's book writing, HTML coding and social media marketing. Her nine books can be found on Amazon.
Federal prosecutors secured prison sentence in long-running Philadelphia oxycodone distribution conspiracy.
PayPal agrees to launch a new Small Business Initiative that excludes criteria based on race, national origin, or other protected characteristics after federal investigation.
New hospital software detects sepsis earlier and improves patient survival chances.
New Mexico seeks court-ordered child protections for Meta social media platforms.
Brain responses to losses may influence emotional resilience and decision-making patterns.
Rising malpractice insurance costs spark debate over lawsuit payout limits.
Judge blocks Spotify class-action case, orders private arbitration proceedings instead.
Potato chip recall issued due to possible salmonella contamination risk nationwide.
Drug combination shows no added benefit for knee arthritis pain.
Fraud scheme billed insurers for unnecessary genetic testing services.